Oncimmune Holdings (GB:ONC) has released an update.
Oncimmune Holdings, a leader in autoantibody profiling for precision medicine, has announced an upcoming live presentation by CEO Martin Gouldstone and Finance Director Martin Hudson. The presentation will discuss the company’s unaudited interim results for H1 FY2024 and is scheduled for May 21, 2024, following their announcement on the same day. Open to all shareholders, the event facilitates direct engagement through a Q&A session, with registration available via Investor Meet Company.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
